Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
10 min read
Vestibular migraine Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
Explore the 2026 Vestibular migraine indication strategy: epidemiology, unmet need, target biology, clinical competition and deal signals using PatSnap MCP evidence.
Latest Hotspot
10 min read
Superior canal dehiscence syndrome Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
2026 Superior canal dehiscence syndrome strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap MCP.
Latest Hotspot
10 min read
Persistent postural-perceptual dizziness Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
2026 Persistent postural-perceptual dizziness strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with.
Latest Hotspot
10 min read
Otosclerosis Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
Explore the 2026 Otosclerosis indication strategy: epidemiology, unmet need, target biology, clinical competition and deal signals using PatSnap MCP evidence.
Latest Hotspot
10 min read
Bilateral vestibulopathy Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
2026 Bilateral vestibulopathy strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap MCP evidence.
Latest Hotspot
10 min read
Autoimmune inner ear disease Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
2026 Autoimmune inner ear disease strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap MCP evidence.
Latest Hotspot
10 min read
Meniere disease refractory Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
2026 Meniere disease refractory strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap MCP evidence.
Latest Hotspot
10 min read
Sudden sensorineural hearing loss Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
2026 Sudden sensorineural hearing loss strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap MCP.
Latest Hotspot
6 min read
SandboxAQ Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
4 August 2026
SandboxAQ 2026 BD opportunity scan covering pipeline assets, ownership, stage, transaction precedents, financial signals, IP risk and outreach priorities.
Latest Hotspot
7 min read
RheumaGen, Inc. Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
4 August 2026
RheumaGen, Inc. 2026 BD opportunity scan covering pipeline assets, ownership, stage, transaction precedents, financial signals, IP risk and outreach priorities.
Latest Hotspot
7 min read
Samjin Pharmaceutical Co., Ltd. Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
4 August 2026
Samjin Pharmaceutical Co., Ltd. 2026 BD opportunity scan covering pipeline assets, ownership, stage, transaction precedents, financial signals, IP risk and outreach priorities.
Latest Hotspot
7 min read
RocketVax AG Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
4 August 2026
RocketVax AG 2026 BD opportunity scan covering pipeline assets, ownership, stage, transaction precedents, financial signals, IP risk and outreach priorities.